kentucky glp-1 gastrointestinal obstruction lawsuit attorney in kentucky semaglutide gastrointestinal obstruction lawyer GLP-1 Attorneys glp-1 constipation law office in

American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists

In June 2025, Amgen announced positive Phase 2 trial results for MariTide showing up to ~20% weight loss in obese patients and ~17% in type 2 diabetes patients, presented at the ADA 85th scientific sessions

More advanced cases of obesity or diabetes may need higher doses, though even those patients might benefit from starting low and escalating only if needed

GLP-1s reduce liver glucose production, too. While many of the benefits do overlap, each class of drugs offers different benefits

Several small-scale human studies have begun to explore these findings in clinical populations

Rapid expansion of GLP-1 therapies disrupts pharma landscape GLP-1 (glucagon-like peptide-1) receptor agonists, once niche products, have captured global attention due to their effectiveness in managing diabetes and supporting weight loss